| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/10/2011 | CN101843871B Chinese medicament for treating diabetic acro-necrosis |
| 08/10/2011 | CN101843836B Chinese medicament for treating diabetic oculopathy |
| 08/10/2011 | CN101843834B Chinese medicament for treating diabetic eyeground pathological changes |
| 08/10/2011 | CN101843833B Chinese medicament for treating diabetic nephropathy |
| 08/10/2011 | CN101732609B Chinese medicament for treating simple obesity |
| 08/10/2011 | CN101695482B Glipizide orally disintegrating tablet and preparation process thereof |
| 08/10/2011 | CN101658510B Coenzyme Q10 self-emulsifying microcapsules and preparation method thereof |
| 08/10/2011 | CN101507796B Medicinal tea capable of treating diabetes and chronic complication thereof |
| 08/10/2011 | CN101496621B Seaweed sausage suitable for diabetic and preparation method thereof |
| 08/10/2011 | CN101486689B DPP-IV inhibitor with sulfonamide formamide piperazine structure |
| 08/10/2011 | CN101406666B Chinese medicine for treating coronary heart disease and angina pectoris, and preparation method and use thereof |
| 08/10/2011 | CN101401849B Uses of tea polyphenol traditional Chinese medicine compound in preparing medicament for reducing blood fat and blood sugar |
| 08/10/2011 | CN101347464B Health products capable of reducing blood sugar and method of preparing the same |
| 08/10/2011 | CN101269211B Shuangtang high calcium medicinal granule and preparation technique |
| 08/10/2011 | CN101260086B Protein-tyrosine-phosphatase 1B inhibitor and its preparation method and use |
| 08/10/2011 | CN101254200B Use of cyclocarya paliurus glycoside compounds for preparing medicament for curing diabetes |
| 08/10/2011 | CN101233128B Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 08/10/2011 | CN101199344B Integrated technology of asparagus' all-nutrient substance |
| 08/10/2011 | CN101167922B Traditional Chinese medicine preparation |
| 08/10/2011 | CN101076329B Methods for purifying trans-(-)-delta,9-tetrahydrocannabinol and trans-(+)-delta,9-tetrahydrocannabinol |
| 08/10/2011 | CN101011499B Linaloe leaf extract, pharmaceutical and health care uses thereof |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994222 Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds |
| 08/09/2011 | US7994217 Prenatal multivitamin/multimineral supplement |
| 08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 08/09/2011 | US7994168 Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids |
| 08/09/2011 | US7994163 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
| 08/09/2011 | US7994159 inhibits proliferation of c-Kit kinase activated-cancer; also mastocytosis, allergy and asthma, which are considered to be caused by c-Kit kinase; 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 08/09/2011 | US7994120 Method of treating dyslipidemic disorder |
| 08/09/2011 | US7994119 Compounds for control of appetite |
| 08/09/2011 | US7993878 Antibodies to human IL-1β |
| 08/09/2011 | US7993676 Free-flowing, powdery composition containing alpha-liponic acid (derivates) |
| 08/09/2011 | CA2512000C Selective estrogen receptor modulator |
| 08/09/2011 | CA2487297C The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 08/09/2011 | CA2459887C Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2438595C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2380058C Novel peptides |
| 08/09/2011 | CA2334941C Tnf-derived peptides for use in treating oedema |
| 08/04/2011 | WO2011094579A2 Mushroom compositions and methods for making and using |
| 08/04/2011 | WO2011094431A1 Sustained-release nsaid/hmg coa reductase inhibitor compositions |
| 08/04/2011 | WO2011094352A1 In-vivo non-viral gene delivery of human vascular endothelial growth factor following islet transplantation |
| 08/04/2011 | WO2011094136A1 Methods of treating glucose metabolism disorders |
| 08/04/2011 | WO2011093664A2 Anti-obesity composition containing (1s,2s,3s,4s)-5-aminocyclopentane-1,2,3,4-tetraol |
| 08/04/2011 | WO2011093501A1 Gpr119 agonist |
| 08/04/2011 | WO2011093469A1 Expression promoter for redox-related factor |
| 08/04/2011 | WO2011092671A1 Proline derivatives for use in the treatment of diabetes |
| 08/04/2011 | WO2011091710A1 Phenyl c-glucoside derivatives, preparation methods and uses thereof |
| 08/04/2011 | WO2011091492A1 Plant extract promoting the scarring of the epidermis and mucous membranes, for topical use and oral administration |
| 08/04/2011 | WO2011069958A3 Low caloric fat replacers |
| 08/04/2011 | WO2011028947A3 Heterocyclic compounds for the inhibition of pask |
| 08/04/2011 | WO2010127237A3 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 08/04/2011 | WO2010095768A8 4 -isopropylphenyl glucitol compounds as sglt1 inhibitors |
| 08/04/2011 | WO2003057161A3 BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190730 Methods of inducing pluripotency involving oct4 protein |
| 08/04/2011 | US20110190729 Methods of inducing pluripotency involving sox2 protein |
| 08/04/2011 | US20110190725 Method for altering drug pharmacokinetics based on medical delivery platform |
| 08/04/2011 | US20110190399 Curcumin nanoparticles and methods of producing the same |
| 08/04/2011 | US20110190395 Novel sulphur containing lipids for use as food supplement or as medicament |
| 08/04/2011 | US20110190394 Carnitine granulate and methods for its production |
| 08/04/2011 | US20110190369 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors |
| 08/04/2011 | US20110190366 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| 08/04/2011 | US20110190355 Heterocyclic indazole derivatives |
| 08/04/2011 | US20110190351 Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190335 Nitrogenated 5-membered heterocyclic compound |
| 08/04/2011 | US20110190330 Spirocyclic gpr40 modulators |
| 08/04/2011 | US20110190327 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 08/04/2011 | US20110190317 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190298 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 08/04/2011 | US20110190296 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190292 Heterobicyclic compounds useful as kinase inhibitors |
| 08/04/2011 | US20110190291 Prodrug and Fluoregenic Compositions and Methods for Using the Same |
| 08/04/2011 | US20110190290 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 08/04/2011 | US20110190277 Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 08/04/2011 | US20110190263 Compounds and compositions as modulators of gpr119 activity |
| 08/04/2011 | US20110190262 Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/04/2011 | US20110190258 Aryl benzylamine compounds |
| 08/04/2011 | US20110190247 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 08/04/2011 | US20110190246 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 08/04/2011 | US20110190240 Nuclear factor kappa b pathway inhibitor composition and use of same |
| 08/04/2011 | US20110190207 Inhibiting binding of fgf23 to the binary fgfr-klotho complex for the treatment of hypophosphatemia |
| 08/04/2011 | US20110190202 Prevention of Cellular Senescence in Mammals by Natural Peptide Complexes |
| 08/04/2011 | US20110190201 Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| 08/04/2011 | US20110190200 GLUCAGON ANALOGS EXHIBITING ENHANCED SOLUBILITY AND STABILITY IN PHYSIOLOGICAL pH BUFFERS |
| 08/04/2011 | US20110190196 Improved peptide mediators of cholesterol efflux |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110189336 Health Beverages Comprising Cinnamon Extract and Methods of Making and Using The Same |
| 08/04/2011 | US20110189318 Methods for enhancing the expression of intracellular redox-associated factors |
| 08/04/2011 | US20110189317 Method for Inhibiting the Activity of DPP-IV and Lowering Blood Glucose Level |
| 08/04/2011 | US20110189316 Composition for controlling increase in blood glucose |
| 08/04/2011 | US20110189313 Method of using a green coffee bean extract to promote carnitine palmitoyltransferase activity |
| 08/04/2011 | US20110189300 siRNA SILENCING OF APOLIPOPROTEIN B |
| 08/04/2011 | US20110189263 Peptides that target dorsal root ganglion neurons |